Amazon’s RxPass Adds To Its Pharmacy Footprint, But Doesn’t Really Compete With Mark Cuban’s Cost Plus Drug Company Amazon is adding RxPass to its pharmacy footprint. Purportedly, it’s competing with Mark Cuban’s Cost Plus Drug Company (MCCPDC). But, limitations suggest it isn’t yet a real competitor.